|Bid||67.46 x 100|
|Ask||67.48 x 300|
|Day's range||66.51 - 67.60|
|52-week range||65.28 - 93.50|
|PE ratio (TTM)||19.71|
|Earnings date||19 Feb 2018 - 23 Feb 2018|
|Forward dividend & yield||N/A (N/A)|
|1y target est||82.64|
Henry Schein (HSIC) tumbled to the bottom of the S&P 500 today after missing third-quarter earnings forecasts and offering below-consensus 2018 guidance. Henry Schein dropped 9.8% to $70.04 today, while ...
The Melville, New York-based company said it had profit of 87 cents per share. The results fell short of Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research ...
Gabelli & Co. Ultimately, we expect Amazon.com to take some share from Henry Schein and Patterson, but expect that dental (and to a lesser extent, veterinary) will be a very difficult market for the company to meaningfully penetrate without an acquisition. It would be difficult for anyone, including Amazon, to build a business to compete with companies like Henry Schein (HSIC) and Patterson that have decades-long relationships with both suppliers and customers (dental and veterinary practices).
Henry Schein's (HSIC) distribution agreement with Terason to distribute the latter's uSmart 3200T NexGen is likely to boost its global Medical segment business.
Henry Schein (HSIC) continues to grow on dental and animal health business, thanks to merger and acquisition activity. However, rising costs continue to be a burden on the company's bottom line.
Jim Cramer shares his take on callers' favorite stocks at lightning speed, including one pharmaceutical giant.